These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3300178)

  • 41. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Trimethoprim-sulfamethoxazole versus amoxycillin in the therapy of acute bacterial exacerbations in chronic non-specific respiratory tract diseases. A controlled study].
    Ramer P; Medici TC; Hatt RR; Unger S; Ronner B
    Schweiz Med Wochenschr; 1981 Nov; 111(48):1823-9. PubMed ID: 7034198
    [No Abstract]   [Full Text] [Related]  

  • 43. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.
    Sachs AP; Koëter GH; Groenier KH; van der Waaij D; Schiphuis J; Meyboom-de Jong B
    Thorax; 1995 Jul; 50(7):758-63. PubMed ID: 7570411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prophylactic sulfamethoxazole and trimethoprim in ventriculoperitoneal shunt surgery. A double-blind, randomized, placebo-controlled trial.
    Wang EE; Prober CG; Hendrick BE; Hoffman HJ; Humphreys RP
    JAMA; 1984 Mar; 251(9):1174-7. PubMed ID: 6363740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant.
    Collet JP; Shapiro P; Ernst P; Renzi T; Ducruet T; Robinson A
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1719-24. PubMed ID: 9412546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trimethoprim-sulfamethoxazole v. amoxicillin in the treatment of acute otitis media.
    Feldman W; Momy J; Dulberg C
    CMAJ; 1988 Nov; 139(10):961-4. PubMed ID: 3052769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.
    Rutten-van Mölken MP; van Nooten FE; Lindemann M; Caeser M; Calverley PM
    Pharmacoeconomics; 2007; 25(8):695-711. PubMed ID: 17640111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children.
    Kovatch AL; Wald ER; Albo VC; Prin W; Orlando SJ; Wollman MR; Phebus CK; Shapiro ED
    Pediatrics; 1985 Nov; 76(5):754-60. PubMed ID: 3903647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial).
    Malerba M; Ponticiello A; Radaeli A; Bensi G; Grassi V
    Pulm Pharmacol Ther; 2004; 17(1):27-34. PubMed ID: 14643168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylactic trimethoprim for prostatectomy.
    Haverkorn MJ
    Urology; 1984 Oct; 24(4):414-8. PubMed ID: 6385444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 months data from three large phase III trials.
    Wedzicha JA; Buhl R; Lawrence D; Young D
    Respir Med; 2015 Jan; 109(1):105-11. PubMed ID: 25433954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical assessment of a trimethoprim-sulfamethopyrazine combination (Kelfiprim) in lower respiratory tract infections.
    Harazim H; John M; Pandelitschka E; Bröll H; Jackwerth G
    J Int Med Res; 1983; 11(4):197-204. PubMed ID: 6352364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antibiotic treatment for acute episodes of chronic obstructive pulmonary disease].
    Alonso Martínez JL; Rubio Obanos MT; Sampériz Legarre AL; Escolar Castellón F; Carrasco del Amo ME
    An Med Interna; 1992 Aug; 9(8):377-80. PubMed ID: 1391559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease.
    Donath E; Chaudhry A; Hernandez-Aya LF; Lit L
    Respir Med; 2013 Sep; 107(9):1385-92. PubMed ID: 23768735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial.
    Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K
    Lancet; 1999 May; 353(9167):1819-23. PubMed ID: 10359405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Norfloxacin versus co-trimoxazole in the treatment of acute bacterial diarrhoea: a placebo controlled study.
    Lolekha S; Patanachareon S; Thanangkul B; Vibulbandhitkit S
    Scand J Infect Dis Suppl; 1988; 56():35-45. PubMed ID: 3074464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and Safety of OM-85 in Patients with Chronic Bronchitis and/or Chronic Obstructive Pulmonary Disease.
    Tang H; Fang Z; Saborío GP; Xiu Q
    Lung; 2015 Aug; 193(4):513-9. PubMed ID: 26044556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Vermeersch K; Gabrovska M; Deslypere G; Demedts IK; Slabbynck H; Aumann J; Ninane V; Verleden GM; Troosters T; Bogaerts K; Brusselle GG; Janssens W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():687-96. PubMed ID: 27099485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.